Pryian completed nearly $50 million in Series C financing.

On July 31, PurYean Medical Technology Co., Ltd. announced that it has completed nearly $50 million in Series C financing. This round of financing was led by Future Asset Capital, with existing shareholders Yahu Investment and Huatai Zijin also participating. The funds raised in this round will primarily be used for the research and development, marketing, channel construction, and expansion of production of multiple injectable medical beauty products.